EA
IMGN

Emerald Advisers’s Immunogen Inc IMGN Stock Holding History

Emerald Advisers’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,744,981
Closed -$51.7M – 267
2023
Q4 		$51.7M Sell
1,744,981
-66,325
-4% -$1.32M 2.21% 1
2023
Q3 		$28.7M Buy
1,811,306
+827,609
+84% +$13.8M 1.39% 15
2023
Q2 		$18.6M Buy
+983,697
New +$11.6M 0.81% 57

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Emerald Advisers's IMGN Position: Q1 2024 in Review

Emerald Advisers sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,744,981 shares — an estimated $51.7M sold.

Emerald Advisers first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $51.7M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Emerald Advisers reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Emerald Advisers sold 1,744,981 Immunogen Inc shares in Q1 2024, an estimated $51.7M.
  • Emerald Advisers first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Emerald Advisers's Immunogen Inc position peaked at $51.7M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Emerald Advisers's 13F filing for Q1 2024, filed 8 May 2024.